MIR6809

gene
On this page

Also known as hsa-mir-6809

Summary

MIR6809 (microRNA 6809, HGNC:49926) is a microRNA gene on chromosome 2q35.

microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.

Source: NCBI Gene 102465485 — RefSeq curated summary.

At a glance

  • Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:49926
Approved symbolMIR6809
NamemicroRNA 6809
Location2q35
Locus typeRNA, micro
StatusApproved
Aliaseshsa-mir-6809
Ensembl geneENSG00000275458
Ensembl biotypemiRNA
Entrez102465485
RNAcentralURS000075C238 — miRNA, 116 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 miRNA

ENST00000612189

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000612189 — 1 exons

ExonStartEnd
ENSE00003746042217900513217900628

Expression profiles

Bgee: expression breadth broad, 95 present calls, max score 86.40.

Top tissues by expression

95 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
sural nerveUBERON:001548886.40gold quality
olfactory segment of nasal mucosaUBERON:000538685.34gold quality
adrenal tissueUBERON:001830383.23gold quality
liverUBERON:000210782.82gold quality
bloodUBERON:000017877.67gold quality
corpus callosumUBERON:000233676.45gold quality
adult mammalian kidneyUBERON:000008276.18gold quality
right lobe of liverUBERON:000111475.86gold quality
cortex of kidneyUBERON:000122575.73gold quality
kidneyUBERON:000211375.73gold quality
skeletal muscle tissueUBERON:000113475.38gold quality
monocyteCL:000057674.90gold quality
muscle of legUBERON:000138374.26gold quality
stomachUBERON:000094574.24gold quality
islet of LangerhansUBERON:000000673.77gold quality
gastrocnemiusUBERON:000138873.46gold quality
descending thoracic aortaUBERON:000234573.37gold quality
popliteal arteryUBERON:000225073.22gold quality
tibial arteryUBERON:000761073.08gold quality
ascending aortaUBERON:000149673.03gold quality
thoracic aortaUBERON:000151572.85gold quality
body of pancreasUBERON:000115072.50gold quality
calcaneal tendonUBERON:000370172.46gold quality
esophagogastric junction muscularis propriaUBERON:003584172.07gold quality
metanephros cortexUBERON:001053371.69gold quality
lower esophagusUBERON:001347371.34gold quality
lower esophagus muscularis layerUBERON:003583371.32gold quality
myometriumUBERON:000129670.98gold quality
muscle layer of sigmoid colonUBERON:003580570.79gold quality
placentaUBERON:000198770.63gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.13

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 2)

  • MiR-6809-5p directly targets flotillin 1 (FLOT1) in hepatoma cells. (PMID:30668319)
  • Long noncoding RNA LINC00675 drives malignancy in acute myeloid leukemia via the miR-6809 -CDK6 axis. (PMID:38422911)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.